Tom Englund’s Post

Eyebot, fueled by a $6 million investment led by AlleyCorp and Ubiquity Ventures, is set to revolutionize vision exams with its AI-powered kiosks, addressing the pressing need for current eyeglass prescriptions in America. By placing self-serve terminals in accessible locations, Eyebot slashes wait times and bypasses optometrist appointments, particularly benefiting underserved rural areas. Matthias Hofmann, Eyebot's CEO, emphasizes the simplicity of the fully automated process, reflecting on previous ventures like EyeNetra. After a quick 90-second exam, teledoctors finalize prescriptions within 24 hours, with consumers given the choice of a $30 fee or a complimentary exam with eyewear purchases. Eyebot's FDA registration ensures safety and compliance, while its revenue model, based on partnerships with eyewear brands, promises to reshape retail experiences. With expansion plans and strong investor backing, Eyebot aims to democratize vision care beyond New England. #Eyebot #VisionCare #AIKiosks #HealthTech #Telemedicine #EyewearRevolution #startup77

We're always looking for ways to improve and streamline our processes. That's why we're thrilled to announce that we've started using LoopedIn to manage our product roadmap! 📈 Why LoopedIn? Enhanced Transparency: LoopedIn allows us to keep our roadmap transparent and accessible to everyone. Our users can now see what we're working on and what's coming next! Better Collaboration: With LoopedIn, we can gather feedback directly from our users and incorporate their ideas into our development process. This ensures that Marvin continues to evolve based on the needs and desires of our community. Real-Time Updates: LoopedIn keeps everyone informed with real-time updates. Whether it's a new feature release or a planned update, our users will always be in the loop! Improved Prioritization: By using LoopedIn, we can better prioritize our tasks based on user feedback and votes. This means we focus on what truly matters to our users. Join Us on This Journey! Check out our roadmap on LoopedIn and share your thoughts. Your feedback is invaluable and helps us make Marvin even better! 💡 👉 https://lnkd.in/egfeJuWq #ProductManagement #Roadmap #UserFeedback #MarvinUpdates #LoopedIn #CustomerEngagement #Transparency #Innovation

As part of Blu Ventures Trailblazers series, we sat down with Nick Delmonico, #CEO and #Founder of Strados Labs, a #RESP #Biosensor device company disrupting the respiratory health industry. Read more about Nick's journey from asthma-sufferer to founder of a #healthtech company that addresses respiratory health from the comfort of a patient's home, his experience with accelerators, lessons learned, and what is on the horizon for the company. https://lnkd.in/eWA6JHuj

Curious to hear Nick Delmonico's story of how he started Strados Labs? Read this enjoyable interview with our investor Blu Ventures that shares how he first came up with the idea for RESP, raised initial funding, received FDA 510(k) clearance, as well as lessons learned along the way. #healthtech #startup #founder #founderstories

Three months ago, I bid farewell to my remarkable 7-year journey at Medtronic. The announcement, which came as a surprise to many, including myself, ultimately became the jolt I needed—both personally and professionally. As I reflect on this period, I take pride in having accomplished the goals I set for myself: ✨ Mastering the art of crafting the perfect ballet bun for my daughter – Check 🏃♂️ Prioritizing health and mental wellness (shedding 26 lbs, daily workouts, and wholesome eating) – Check 🧗♂️ Elevating my climbing regimen – Check 👨👩👧👦 Strengthening family bonds with quality time – Check 📖 Cultivating a daily reading habit – Check 🏊♀️ Winning the Walter A Bauman 2023 Splash Contest – Check Amidst these personal accomplishments, I've also reached significant professional milestones. The desire to immerse myself in the startup community has long been a goal, but the perpetual balance between work trips and family responsibilities often posed a challenge to find the time. This 3 month hiatus provided the window of opportunity I needed to dive into my passions—technology, entrepreneurship, and AI. Today, I'm thrilled to unveil the first of many forthcoming announcements. I am delighted to announce my CRO partnership with the RedFox AI team, delivering a pioneering process-aware system to the market. Our innovation empowers businesses to seamlessly integrate AI into their offerings through a tailor-made AI system, bridging the last mile communication gap with customers. Over the past month, we've made astounding progress—refining our platform, shaping our go-to-market strategy, enhancing user experience, and forging exclusive channel partnerships (stay tuned for more!). We're poised to drive substantial growth and redefine the AI landscape. Amidst the exhilarating AI era, I firmly believe we've barely touched the surface of its potential. Collaborating with RedFox AI to spearhead a transformative shift in unlocking end-user value marks just the beginning. There is a lot more to come over the coming months on other projects I'll be launching, both on my own and in partnership with RedFox AI. Sometimes we're dealt cards in life, it truly is up to us what we do with them. More to come on this journey..... #aiinnovation #newbeginnings #RedFox AI

SimadIlab truely changed people from zero to advanced with digital skills, thanks SimadIlab

“Together with A*STAR, we are committed to building an agile and resilient Joint Lab housed in Mirxes’ Industry 4.0 in-vitro diagnostic manufacturing facility the first and largest in Southeast Asia.” – Mr Jeremiah Decosta, Vice President, Operations of Mirxes.   “The collaboration with ARTC will allow us to deploy cutting edge robotic solutions to transform the field of airport logistics.” – Mr Daniel Lim , Chief Executive Officer of M8M.   The newly launched joint labs with M8M and Mirxes will bring together expertise and knowledge from ARTC and industry partners to co-develop advanced manufacturing solutions in enhancing productivity and competitiveness.   The Mirxes – A*STAR Joint Lab aims to develop an intelligent in-vitro diagnostic manufacturing solution to streamline manufacturing processes in the MedTech industry. These developments of more accessible and affordable preventive healthcare solutions will support in broadening the range of products such as for early cancer detection. Through our partnership, Mirxes will build a Future-Ready Medtech manufacturing ecosystem, fortifying the local and global diagnostics value chain.    The M8M – A*STAR Joint Lab aims to develop an autonomous and intelligent baggage handling system that will eliminate unergonomic repetitive tasks and streamline operation processes through automation. With these developments, M8M will transform the field of airport logistics by accelerating airport transformation into a smart, automated airport. We look forward to future collaborations in Shaping the Future of Manufacturing through Innovation.    Discover more about the Joint Labs and their objectives in this video. #ARTC #InnovationCollaboration #M8M #Mirxes #JointLabs #AdvancedManufacturing

Mike McDonald, CFO and COO of Aesthetic Management Partners (AMP), shares how MedShift's Velocity Technology Suite has streamlined business operations, freeing valuable time for strategic growth initiatives. At MedShift, we are committed to helping aesthetic businesses thrive in an increasingly competitive landscape. To learn more about Velocity's capabilities and how the platform can help your business achieve impressive growth, book a personalized demo at https://ow.ly/pqTS50Qc8FJ. #MedShift #Velocity #VelocityTechnologySuite #MedicalTechnology #MedTech #AMP #AestheticManagementPartners

Join the conversation this Thursday as we unwind the story of Aether Biomedical with Dr. Faith Jiwakhan, co-founder and CCO of Aether Biomedical. Aether Biomedical is a pioneering startup that crafts prosthetic, robotic hands for amputees. Get ready to be inspired by every chapter we unfold to dive deep into the story of Aether. They are making a remarkable impact with their strongest product: Zeus! 😉 More on this later on April 10, 2024! Follow Newzchain for all the updates. #AetherBiomedical #RoboticHands #TheNewzchainPodcast #Newzchain